Full Schedule

Speaker: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Speaker: Wendy Bursey, RN CON(c) (she/her/hers) – Juravinski Cancer Centre

Co-Chair: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Co-Chair: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Speaker: Tak W. Mak, PhD – Princess Margaret Cancer Centre at University Health Network

Panelist: Tak W. Mak, PhD – Princess Margaret Cancer Centre at University Health Network

Chair: Wendy Bursey, RN CON(c) (she/her/hers) – Juravinski Cancer Centre

Chair: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Speaker: Chantelle Hughes, RN, MNursSci (she/her/hers) – University College London Hosptial

Speaker: Mary Steinbach, DNP – Huntsman Cancer Institute/University of Utah

Speaker: Sara A. Scott, PharmD, BCOP (she/her/hers) – Winship Cancer Institute, Emory University

Abstract Presenter: Ty Simpson, RN (he/him/his) – The Alfred Hospital

Abstract Presenter: Dior Caruso, MN-NP Adult, CHPCN(C) – Princess Margaret Cancer Centre

Abstract Presenter: Jennifer Russell, MSc, BSc (Hons) – University College London Hospital

Chair: Vincent Rajkumar, MD – Mayo Clinic

Co-Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca

Speaker: Mehmet K. Samur, PhD – Dana Farber Cancer Institute, Harvard Medical School

Speaker: Madhav V. Dhodapkar, MD, (he/him/his) – Fred Hutch Cancer Center, Seattle, WA

Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Speaker: Natalie Callander, MD – University of Wisconsin

Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Panelist: Jesus San Miguel, PhD. MD. (he/him/his) – Cancer Center Clínica Universidad de Navarra

Panelist: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

Panelist: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Panelist: Peter Leif Bergsagel, MD – Mayo Clinic Arizona

Panelist: Chantelle Hughes, RN, MNursSci (she/her/hers) – University College London Hosptial

Panelist: Mary Steinbach, DNP – Huntsman Cancer Institute/University of Utah

Panelist: Sara A. Scott, PharmD, BCOP (she/her/hers) – Winship Cancer Institute, Emory University

Chair: Monica Morris, RN, MSc – Myeloma UK

Chair: Tracy King, PhD, MSc, RN (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital The University of Sydney

Speaker: Margaret McNeely, PhD (she/her/hers) – University of Alberta

Abstract Presenter: Jenna Tate, Master of Science in Advanced Clinical Practice, Registered Nurse (Adult) – Leeds Teaching Hospitals

Abstract Presenter: Donna D. Catamero, ANP-BC – Mount Sinai Hospital

Abstract Presenter: Daniela Klarica, NP – Alfred Health

Speaker: Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Moderator: Tracy King, PhD, MSc, RN (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital The University of Sydney

Panelist: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Panelist: Margaret McNeely, PhD (she/her/hers) – University of Alberta

Panelist: Tina M. Crosbie, BSc. (Pharm), ACPR, RPh (she/her/hers) – The Ottawa Hospital

Co-Chair: Rafat Abonour, Professor – Indiana University School of Medicine

Co-Chair: Meral Beksac, MD (she/her/hers) – Istinye University Ankara Liv Hospital, Department of Hematology

Abstract Presenter: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Abstract Presenter: Hira Mian, MD (she/her/hers) – McMaster University, Hamilton, ON, Canada

Abstract Presenter: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Abstract Presenter: Meera Mohan, MD – Medical College of Wisconsin

Abstract Presenter: Hang Quach, MBBS(Hons) FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Co-Chair: Manoj Bhasin, PhD – Emory University

Co-Chair: Jill Corre, PharmD PhD (she/her/hers) – Unité de Génomique du Myélome, University Hospital, IUCT-Oncopole, CRCT, Toulouse, France

Abstract Presenter: Jeremy Er, Bmed Sci, MBBS, FRACP, FRCPA – Hawkins laboratory, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia Clinical haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

Abstract Presenter: Francesco Maura, MD – Memorial Sloan Kettering

Abstract Presenter: Elena Maroto Martin, PhD (she/her/hers) – Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School

Abstract Presenter: Oliver Van Oekelen, MD, PhD – Icahn School of Medicine at Mount Sinai

Abstract Presenter: Tarek H. Mouhieddine, MD (he/him/his) – Dana-Farber Cancer Institute

Faculty: Efstathios Kastritis, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Faculty: Angela Dispenzieri, MD – Mayo Clinic Rochester

Faculty: Ramon Garcia Sanz, PhD (he/him/his) – Dept. of Hematology, Gregorio Marañón General University Hospital

Faculty: Victor H. Jimenez Zepeda, MD – Arthur JE Child Comprehensive Cancer Center

Faculty: Ben Derman, MD – University of Chicago

Faculty: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)

Co-Chair: Hartmut Goldschmidt, MD (he/him/his) – Internal Medicine V, GMMG Study Group at University Hospital Heidelberg, Heidelberg, Germany

Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre

Abstract Presenter: Rongfang Wei, PhD – Department of Hematology, The Eighth Affiliated Hospital, Sun Yat-sen University

Abstract Presenter: Maria Josic, MS – Pfizer

Abstract Presenter: Carlyn Rose Tan, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center

Abstract Presenter: Michael D. Amatangelo, PhD – Bristol Myers Squibb, Summit, NJ, USA

Abstract Presenter: Uday Yanamandra, MD (DM) – AFMC , Pune

Abstract Presenter: William C. Pilcher, Jr., BsC (he/him/his) – Emory University

Abstract Presenter: Yuntong Liu, liuyuntong@ihcam.ac.cn – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Abstract Presenter: Amandeep Godara, MD – University of Utah

Speaker: Monica Morris, RN, MSc – Myeloma UK

Chair: Luciano J. Costa, MD – University of Alabama Birmingham Hospital

Speaker: Krina K. Patel, MD, MSc (she/her/hers) – Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center

Speaker: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Speaker: Luciano J. Costa, MD – University of Alabama Birmingham Hospital

Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT

Speaker: Joshua Richter, MD – Icahn School of Medicine at Mount Sinai

Speaker: Luciano J. Costa, MD – University of Alabama Birmingham Hospital

Speaker: Luciano J. Costa, MD – University of Alabama Birmingham Hospital

Chair: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France

Co-Chair: Francesca Gay, MD (she/her/hers) – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Speaker: Aurore Perrot, MD, PhD – University of Toulouse, University Hospital Department of Hematology, IUCT Oncopole, CRCT, Toulouse, France

Speaker: Martin F. Kaiser, MD, FRCP, FRCPath (he/him/his) – The Institute of Cancer Research; Royal Marsden Hospital

Speaker: Ashley Rosko, MD (she/her/hers) – The Ohio State University

Speaker: Sonja Zweegman, MD, PhD – Amsterdam UMC

Panelist: Hira Mian, MD (she/her/hers) – McMaster University, Hamilton, ON, Canada

Panelist: Gordon Cook, PhD, DSc – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK

Panelist: Arleigh McCurdy, MD MHA FRCPC – The Ottawa Hospital, University of Ottawa, Canada

Co-Chair: Andrzej Jakubowiak, MD, PhD – The University of Chicago

Co-Chair: Robert Z. Orlowski, MD, PhD (he/him/his) – Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center

Abstract Presenter: Marina Hajiyianni, MD – Heidelberg Myeloma Center, Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany

Abstract Presenter: Aaron S. Rosenberg, MD, MS – UC Davis Comprehensive Cancer Center

Abstract Presenter: Marco Talarico, marco.talarico – Università di Bologna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli"

Abstract Presenter: Hira Mian, MD (she/her/hers) – McMaster University, Hamilton, ON, Canada

Abstract Presenter: Alissa Visram, MD, MPH – Juravinski Cancer Centre / Hamilton Health Sciences

Co-Chair: Francesco Maura, MD – Memorial Sloan Kettering

Co-Chair: Diana Cirstea, MD – Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School

Abstract Presenter: Anjana Anilkumar Sithara, MS – University of Ostrava

Abstract Presenter: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany

Abstract Presenter: Anna Besschetnova, PhD (she/her/hers) – Dana-Farber Cancer Institute

Abstract Presenter: Joshua Rivera, PhD – Dana-Farber Cancer Institute

Abstract Presenter: Denis J. Ohlstrom (he/him/his) – Georgia Institute of Technology

Co-Chair: Vincent Rajkumar, MD – Mayo Clinic

Co-Chair: Joan Blade, PhD (he/him/his) – Hospital Clinic de Barcelona

Speaker: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Speaker: Noopur Raje, MD – Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School

Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Speaker: Josefine Krüger, MD – Columbia University Irving Medical Center

Speaker: Sara Gandolfi, MD, PhD – University of Helsinki

Moderator: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Moderator: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Moderator: Noopur Raje, MD – Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School

Panelist: Jelena Bila, MD, PhD – Clinic of Hematology, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade

Panelist: Lindokuhle N. Goqwana, MD (she/her/hers) – University of the Witwaterand

Panelist: Angelo Maiolino, MD, PhD – Universidade Federal do Rio de Janeiro

Panelist: Uday Yanamandra, MD (DM) – AFMC , Pune

Chair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Paul G. Richardson, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Speaker: Peter M. Voorhees, MD – Levine Cancer Institute, Atrium Health, Charlotte, NC, USA

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany

Speaker: Martine Elias, M.Sc. (she/her/hers) – Myeloma Canada

Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Speaker: Paola Neri, MD, PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary

Speaker: Samir Parekh, MD (he/him/his) – Mount Sinai Medical Center, New York, NY, USA

Speaker: Surbhi Sidana, MD – Stanford University School of Medicine

Speaker: Benjamin Puliafito, MD – Massachusetts General Hospital

Speaker: Niels W.C.J. van de Donk, MD, PhD (he/him/his) – Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

Panelist: Adam D. Cohen, MD – Perelman School of Medicine, University of Pennsylvania

Panelist: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Panelist: Morie A. Gertz, MD – Mayo Clinic Rochester

Panelist: Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD – NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK

Chair: Jean-Sébastien Claveau, MD – Maisonneuve-Rosemont hospital

Speaker: Jean-Sébastien Claveau, MD – Maisonneuve-Rosemont hospital

Speaker: Alissa Visram, MD, MPH – Juravinski Cancer Centre / Hamilton Health Sciences

Speaker: Binod Dhakal, MD, MS – Medical College of Wisconsin

Speaker: Roberto Mina, MD – Università degli Studi di Torino

Speaker: Jean-Sébastien Claveau, MD – Maisonneuve-Rosemont hospital

Faculty: Yi Lin, MD, PhD – Mayo Clinic

Faculty: Ajay K. Nooka, MD, MPH, FACP (he/him/his) – Winship Cancer Institute of Emory University

Faculty: Yaël C. Cohen, MD (she/her/hers) – Tel-Aviv Sourasky (Ichilov) Medical Center

Faculty: Wilson I. Gonsalves, MD (he/him/his) – Mayo Clinic, Rochester

Faculty: Steven Peter Treon, MD, MA, MS, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute

Faculty: Prashant Kapoor, MD – Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA

Co-Chair: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Co-Chair: Craig Emmitt Cole, MD (he/him/his) – Karmanos Cancer Institute-Wayne State and Michigan State University

Abstract Presenter: Kirsten Pfeffer, PhD – Mayo Clinic

Abstract Presenter: Jin Lu, Professor – Peking University People's Hospital

Abstract Presenter: Zhen Cai, MD (she/her/hers) – Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University

Abstract Presenter: Robert Z. Orlowski, MD, PhD (he/him/his) – Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center

Abstract Presenter: Salomon Manier, MD, PhD – Hematology Department, Lille University Hospital, Lille, France

Abstract Presenter: Vincent Luong, MD (he/him/his) – Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet and Department of Hematology, Karolinska University Hospital, Sweden

Abstract Presenter: Krina K. Patel, MD, MSc (she/her/hers) – Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center

Abstract Presenter: Liam D. Hendrikse, PhD – University Health Network

Co-Chair: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN

Speaker: Niccolo Bolli, MD, PhD – University of Milan/Policlinico Hospital

Speaker: Sandrine Roulland, PharmD, PhD (she/her/hers) – Inserm

Co-Chair: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Speaker: Peter Leif Bergsagel, MD – Mayo Clinic Arizona

Speaker: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca

Abstract Presenter: Adam D. Cohen, MD – Perelman School of Medicine, University of Pennsylvania

Abstract Presenter: Bertrand Arnulf, MD, PhD (he/him/his) – Service d'Immunologie Hématologie Hôpital Saint-Louis

Abstract Presenter: Anna Smit, MSc – Department of Hematology, Erasmus University Medical Center Cancer Institute

Abstract Presenter: Ajay K. Nooka, MD, MPH, FACP (he/him/his) – Winship Cancer Institute of Emory University

Abstract Presenter: Verónica González-Calle, MD, PhD (she/her/hers) – Hematology Department, University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC)

Abstract Presenter: Jesus San Miguel, PhD. MD. (he/him/his) – Cancer Center Clínica Universidad de Navarra

Co-Chair: Nisha S. Joseph, MD – Winship Cancer Institute, Emory University

Co-Chair: Douglas E. Joshua, Professor (he/him/his) – University of Sydney

Abstract Presenter: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.

Abstract Presenter: Benjamin Puliafito, MD – Massachusetts General Hospital

Abstract Presenter: David M. Cordas dos Santos, MD (he/him/his) – Dana-Farber Cancer Institute

Abstract Presenter: Hitomi Hosoya, MD,PhD – Cedars-Sinai Medical Center

Abstract Presenter: Saad Z. Usmani, MD, MBA, FACP, FASCO – Memorial Sloan Kettering Cancer Center

Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center

Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.

Abstract Presenter: Adolfo Aleman, PhD – Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai

Abstract Presenter: Lorenzo Lindo, BSc (he/him/his) – Basic and Translational Department, BC Cancer Research Institute

Abstract Presenter: David Jung, BSc (he/him/his) – University of Calgary

Abstract Presenter: Matthew Ho, MD, PhD – University of Pennsylvania

Abstract Presenter: Bruno Paiva, PhD – Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain

Chair: Ajai Chari, MD – University of California, San Francisco

Speaker: Ajai Chari, MD – University of California, San Francisco

Speaker: Guido Lancman, MD, M.Sc. – University of Toronto, Princess Margaret Cancer Centre

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Speaker: Ajai Chari, MD – University of California, San Francisco

Chair: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Speaker: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain

Speaker: Janet A. MacEachern, MD FRCPC – Waterloo Regional Health Network

Speaker: Arlene A. Gayle, MD (she/her/hers) – AdventHealth Medical Group

Chair: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Co-Chair: Charlotte Pawlyn, PhD, FRCP, FRCPath (she/her/hers) – The Institute of Cancer Research and The Royal Marsden Hospital

Speaker: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo

Speaker: Amrita Krishnan, MD – City of Hope Orange County

Speaker: Katja C. Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany

Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes

Speaker: Saad Z. Usmani, MD, MBA, FACP, FASCO – Memorial Sloan Kettering Cancer Center

Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Panelist: Pieter Sonneveld, MD, PhD (he/him/his) – EMN

Panelist: Meletios A. Dimopoulos – National and Kapodistrian University of Athens, Athens, Greece

Panelist: Hang Quach, MBBS(Hons) FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Chair: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Speaker: Claudio Cerchione, MD, PhD (he/him/his) – Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS

Speaker: Elizabeth O'Donnell, MD – Dana-Farber Cancer Institute

Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Faculty: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Faculty: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Faculty: Jose Martinez Climent, MD, PhD (he/him/his) – University of Navarra

Faculty: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona

Faculty: Pankaj Malhotra, MD (he/him/his) – Postgraduate Institute of Medical Education and Research, Chandigarh

Faculty: Dorotea Fantl, MD (she/her/hers) – Hospital Italiano de Buenos Aires, Argentina.

Co-Chair: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Co-Chair: P.Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital

Abstract Presenter: Omar Nadeem, MD – Dana-Farber Cancer Institute

Abstract Presenter: Lili Zhou, MD & PhD. (she/her/hers) – Shanghai SinoUnited Hospital, China

Abstract Presenter: Evangelos Terpos, MD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Abstract Presenter: Saurabh Zanwar, MD – Mayo Clinic

Abstract Presenter: Taro Hitosugi, PhD – Mayo Clinic

Abstract Presenter: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT

Abstract Presenter: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca

Abstract Presenter: Ioannis Ntanasis-Stathopoulos, MD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Co-Chair: Evangelos Terpos, MD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Co-Chair: Sundar Jagannath, MD, FASCO (he/him/his) – Mount Sinai Medical Center, New York, NY, USA

Speaker: Adam D. Cohen, MD – Perelman School of Medicine, University of Pennsylvania

Abstract Presenter: Chenxing Du, MD, PhD (she/her/hers) – Institute of Hematology and Blood Diseases Hospital

Speaker: Bruno Paiva, PhD – Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain

Abstract Presenter: Ludovic Martinet, PhD (he/him/his) – Cancer research center of Toulouse, iuct-oncopole, CHU Toulouse

Speaker: Jill Corre, PharmD PhD (she/her/hers) – Unité de Génomique du Myélome, University Hospital, IUCT-Oncopole, CRCT, Toulouse, France

Abstract Presenter: Anais Schavgoulidze, PharmD PhD (she/her/hers) – IUCT Oncopole Toulouse

Speaker: Richard LeBlanc, MD (he/him/his) – Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada

Abstract Presenter: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Speaker: Hira Mian, MD (she/her/hers) – McMaster University, Hamilton, ON, Canada

Abstract Presenter: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Speaker: Bobby W. Sandage, Jr., PhD – Paula and Rodger Riney Foundation

Speaker: Mohammad Rashidian

Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University

Speaker: Josefine Krüger, MD – Columbia University Irving Medical Center

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Anna Smit, MSc – Department of Hematology, Erasmus University Medical Center Cancer Institute

Panelist: Jenny Ahlstrom, n/a – HealthTree Foundation

Panelist: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Panelist: Edward Laane, MD, PhD (he/him/his) – Tartu University

Panelist: Vincent Rajkumar, MD – Mayo Clinic

Panelist: Anna Smit, MSc – Department of Hematology, Erasmus University Medical Center Cancer Institute

Chair: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center

Speaker: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center

Speaker: Michael Sebag, MD, PhD (he/him/his) – McGill University Health Centre

Speaker: Judith S. Hecker, PD Dr. med. (she/her/hers) – TUM University Hospital, Munich Germany

Speaker: Ciara L. Freeman, Dr (she/her/hers) – H Lee Moffitt Cancer Center and Research Institute

Speaker: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center

Co-Chair: Damian Green, MD (he/him/his) – Sylvester Comprehensive Cancer Center/University of Miami

Co-Chair: Melissa Alsina, MD (she/her/hers) – H. Lee Moffitt Cancer Center

Abstract Presenter: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Abstract Presenter: Arthur F. Bobin (he/him/his) – University Hospital of Poitiers

Abstract Presenter: Verónica González-Calle, MD, PhD (she/her/hers) – Hematology Department, University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC)

Abstract Presenter: Larry D. Anderson, Jr., MD, PhD (he/him/his) – Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

Abstract Presenter: Andrzej Jakubowiak, MD, PhD – The University of Chicago

Co-Chair: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS (he/him/his) – National University Cancer Institute, Singapore

Co-Chair: Bruno Paiva, PhD – Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain

Abstract Presenter: Julia Erin Wiedmeier-Nutor, MD. MPH – Mayo Clinic

Abstract Presenter: Luca Bertamini, MD (he/him/his) – Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

Abstract Presenter: Mattia D'Agostino, MD – Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy

Abstract Presenter: Silvia Armuzzi, MS (she/her/hers) – Department of Medical and Surgical Sciences - University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna

Abstract Presenter: Wilson I. Gonsalves, MD (he/him/his) – Mayo Clinic, Rochester

Co-Chair: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University

Co-Chair: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain

Abstract Presenter: Bruno Paiva, PhD – Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain

Abstract Presenter: Lærke Sloth Andersen, MD (she/her/hers) – Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Abstract Presenter: Francesco Maura, MD – Memorial Sloan Kettering

Abstract Presenter: Daniel SL Wong, MBBS, FRACP, FRCPA – Alfred Health

Abstract Presenter: Sungjae Kim, PhD – Cancer Program, Broad Institute

Co-Chair: Vania Hungria, MD, PhD (she/her/hers) – Clinica São Germano

Co-Chair: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine

Abstract Presenter: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Abstract Presenter: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain

Abstract Presenter: Febe Smits, MD – Department of Hematology, Amsterdam UMC, Amsterdam, The Netherlands

Abstract Presenter: Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University

Abstract Presenter: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Co-Chair: Christine I. Chen, MD, FRCPC, MEd (she/her/hers) – PRINCESS MARGARET CANCER CENTRE

Co-Chair: Joaquin Martínez-López, MD PhD (he/him/his) – H 12 de Octubre/Complutense University

Speaker: Chetasi Talati, MD (she/her/hers) – AbbVie

Speaker: Michael D. Amatangelo, PhD – Bristol Myers Squibb, Summit, NJ, USA

Speaker: Jordan M. Schecter, MD (he/him/his) – Johnson & Johnson Innovative Medicine

Speaker: Ana Kostic, MD (she/her/hers) – Arcellx, Inc.

Speaker: Arun Balakumaran, MD, PhD – Pfizer

Speaker: Glenn S. Kroog, MD (he/him/his) – Regeneron Pharmaceuticals, Inc

Co-Chair: Jesus G. Berdeja, MD (he/him/his) – Tennessee Oncology

Co-Chair: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain

Abstract Presenter: Binod Dhakal, MD, MS – Medical College of Wisconsin

Abstract Presenter: Binod Dhakal, MD, MS – Medical College of Wisconsin

Abstract Presenter: Masa Lasica, MBBS, FRACP, FRCPA – St Vincent's Hospital Melbourne

Abstract Presenter: Hang Quach, MBBS(Hons) FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Abstract Presenter: Doris K. Hansen, MD – Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center

Co-Chair: Mariateresa Fulciniti, PhD – Dana-Farber Cancer Institute

Co-Chair: Jill Corre, PharmD PhD (she/her/hers) – Unité de Génomique du Myélome, University Hospital, IUCT-Oncopole, CRCT, Toulouse, France

Abstract Presenter: Dorothee Winterberg, PhD (she/her/hers) – University Medical Center Schleswig-Holstein

Abstract Presenter: Lanting Liu, MD – State Key Laboratory of Experimental Hematology; National Clinical Research Center for Blood Diseases;Haihe Laboratory of Cell Ecosystem; Institute of Hematology & Blood Diseases Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College

Abstract Presenter: Xiyue Sun, PhD student (she/her/hers) – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Abstract Presenter: James J. Driscoll, MD, PhD (he/him/his) – Case Western Reserve University

Abstract Presenter: Lawrence H. Boise, PhD – Emory University

Co-Chair: Donna E. Reece, MD (she/her/hers) – University Health Network, Princess Margaret Cancer Centre

Co-Chair: Rafael Fonseca, MD – Mayo Clinic

Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Speaker: Lawrence H. Boise, PhD – Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA, USA

Speaker: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Co-Chair: Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University

Co-Chair: Masahiro Abe, MD PhD (he/him/his) – Kawashima Hospital

Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Speaker: Noopur Raje, MD – Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School

Speaker: Thomas Martin, MD – UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA

Speaker: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France